No Data
No Data
Johnson & Johnson Retains 'AAA' Rating at S&P, Credit Outlook Stable
TD Cowen Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $185
HSBC Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Raises Target Price to $184
Will the US Stock Market's Rebound Ignite Your Next Trade?
Reported Saturday, Johnson & Johnson's TAR-200 Monotherapy Demonstrates Strong Early Efficacy In BCG-Unresponsive Bladder Cancer, Achieving Over 80% Disease-Free Survival
Express News | Johnson & Johnson : HSBC Raises Target Price to $184 From $180
loading...